A B S T R A C T The daily transport of human plasma apolipoproteing A-I and A-II, triglyceride, and total cholesterol from the thoracic duct lymph into plasma was measured in two subjects before and three subjects after renal transplantation. Lymph triglyceride transport was -83% of the daily ingested fat loads, whereas lymph cholesterol transport was consistently greater than the amount of daily ingested cholesterol. Lymph apolipoprotein transport significantly (P < 0.05) exceeded the predicted apolipoprotein synthesis rate by an average of 659±+578 mg/d for apolipoprotein A-I and 109+59 mg/d for apolipoprotein A-II among the five subjects. It is estimated that 22-77% (apolipoprotein A-I) and 28-82% (apolipoprotein A-II) ofdaily total body apolipoprotein synthesis takes place in the intestine.
INTRODUCTION
The biosynthesis ofapolipoproteins (apo)' A-I and A-II in man and their subsequent incorporation into plasma high density lipoproteins (HDL) is presently an area of active research. In the rat, both hepatic parenchymal and absorptive epithelial cells of the small intestine have been shown to synthesize apoA-I (1-6). Human apoA-I and apoA-II have been localized by immunochemical techniques in intestinal epithelial cells (7) (8) (9) . Although some apolipoproteins synthesized in the intestine may enter the blood plasma directly (6), a major portion of the apolipoproteins is thought to be carried by mesenteric lymph lipoproteins into the thoracic duct lymph and subsequently into the venous circulation (2, (4) (5) (6) 8) .
Human thoracic duct lymph contains lipoproteins of all density classes (10) and a majority of the circulating apolipoproteins (11) , including apoA-I and apoA-II. Thoracic duct lymph, which is an admixture of lymph from abdominal organs (e.g., liver and intestine) and the periphery, flows into the blood circulation at a rate of between 50-100%o of the plasma volume per day (12) . Upon mixing with blood, the apoA-I and apoA-II car-ried by the lymph can be incorporated into plasma HDL by two mechanisms: (a) transfer to plasma HDL from less dense lipoproteins such as chylomicrons (13, 14) ; and (b) as components of lymph HDL that is transformed into plasma HDL. Plasma HDL, in turn, may reach the lymphatic circulation by filtration from peripheral and visceral capillary beds (15) . Specifically, an indirect indication of apoA-I and apo-A-II transport between plasma and lymph in man comes from four different metabolic studies (16) (17) (18) (19) . In each of these studies, compartmental analysis of apolipoprotein catabolism data required the labeled apoA-I or apoA-II in plasma to exchange with an extravascular space. The lymph likely occupies a sizeable portion of that space. Determination ofthe temporal apoA-I and apoA-II contribution by human thoracic duct lymph to blood circulation is therefore critical in assessing not only the quantitative aspects of lymph apolipoprotein incorporation into plasma HDL, but also the extent of daily intestinal synthesis of these apolipoproteins and the extent of daily lymph apoA-I and apoA-II filtration from plasma.
In the following work, we have undertaken to quantitate the daily transport of apoA-I, apoA-II, triglyceride, and total cholesterol from thoracic duct lymph into plasma, and to determine the distribution of these components among lymph lipoprotein classes. In addition, the composition and physical properties of lymph HDL are compared with those of plasma HDL.
METHODS
Description of subjects. Lymph was obtained by cannulation of the thoracic duct in five subjects undergoing lymph drainage for purposes of immunosuppression either before kidney transplantation (subjects A and B) or after transplantation (subjects C, D, and E). Subjects A and B, both males ages 33 and 45 yr, were dialyzed three times per week. For these subjects, 24-h lymph collection was begun 1 d after dialysis. For subjects C, D, and E, males age 18, 22 and 27 yr, 24-h lymph collection was begun 6 (C), 10 (D), and 11 d (E) after successful kidney transplantation. These three subjects had relatively normal renal function (blood creatinine c 1.5 mg/dl and blood urea nitrogen c 30 mg/dl). The five subjects maintained constant weight on an ad lib diet of 2,000-3,700 kcal/d. Dietary cholesterol intake was estimated from standard tables (20) as 0.25-0.75 g/d. Plasma triglyceride and cholesterol concentrations, shown in Table I , were within normal ranges for age and sex-matched controls (21) . Furthermore, the concentrations of both lipids did not vary greatly during the 24-h collection period for subjects B, C, D, and E. These data were not available for subject A. The plasma concentrations of apolipoproteims A-I and A-II are also given in Table I . They were also similar before and after the 24-h collection period for subjects B, C, D, and E. The normal range in our laboratory for plasma apoA-I is 131.0±16.0 (SD) mg/dl and for apoA-II, 28 .0+2.8 mg/dl (22) .
Lymph collection. For each subject lymph collection was begun just before the morning meal and carried ouit continuously for 24 h in a series of from 8 to 15 sterile collection bags. Noon and evening meals were taken at 12:00 a.m.-1:00 p.m. and 5:00-6:00 p.m., respectively. A sample for analysis (20 ml) was withdrawn from each bag. After lymphocyte removal, the remaining lymph (200-700 ml) was sterilized and returned to the subject by continuous intravenous infusion within 3-4 h of its initial collection. Each subject had been maintained on this schedule for at least 2 wk before the 24-h period, during which samples for analysis were taken. Thus the loss of lymph lipoprotein material to the subject was insignificant. All samples for analysis collected from a given patient were then recombined in proportion to the particular fraction of daily lymph output volume that they represented. In this way, one sample representing the patients' average lymph composition over the 24-h period was obtained. This sample was used for each of the analyses described below.
Electron microscopy. Samples for electron microscopy were prepared according to the negative stain technique described by Forte and Nichols (23) .
Lipid and protein analysis. Phospholipid concentrations in lymph and plasma samples were determined as lipid phosphorus by the method of Chalvardjian (24) . Total cholesterol and triglyceride concentrations were measured using the Autoanalyzer II (Technicon Instruments, Inc., Tarrytown, N. Y.) (25) . Unesterified cholesterol was measured with the Beckman oxygen-enzymic analyzer (26) (Beckman Instruments, Inc., Fullerton, Calif.) and cholesteryl ester caleculated as 1.68 x (total cholesterol -unesterified cholesterol). Total protein was determined by the method of Lowry et al. (27) .
Analytic ultracentrifugation. Analytic ultracentrifugation of both lymph and plasma samples was performed and the computer-derived schlieren patterns were obtained by pro- cedures (28) that corrected for the concentration dependence of the flotation rate and the Johnston-Ogston effect. HDLSb, HDL2a, and HDL3 concentrations were determined as previously described (29) .
Apolipoprotein quantitation. The concentration ofapoA-I and apoA-II in all samples was measured both by electroimmunoassay (30) and radial immunodiffusion (31 Table II .
Column chromatography. Gel permeation chromatography was performed with a 100 x 1.2-cm column (Kontes Co., Vineland, N. J.) of Sepharose 6B-CL (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) in NaCl-EDTA buffer (0.85% NaCl, 0.01% EDTA, 1 mM sodium azide, pH 7.4) at room temperature (24°C). Sample volumes applied to the column were 5 ml, and flow rates were -21 ml/h. Preparations of HDL and low density lipoproteins (LDL) applied to this column were isolated from a normolipemic individual by ultracentrifugation as described below. Lipoprotein preparations. Lymph and plasma were collected in heparinized containers with a final heparin concentration of 1 U/cm3. To inhibit the action of lecithin:cholesterol acyltransferase (LCAT), 5,5'-dithionitrobenzoic acid (DTNB) in 0.75 M phosphate buffer, pH 7.4, was added during collection of selected aliquots of lymph to a final concentration of 1 mM. Lymph chylomicrons were isolated as the upper 5-ml fraction after 25 ml ofwhole lymph, layered beneath 5 ml ofNaCl-EDTA buffer, was centrifuged for 3 x 106g-min. After chylomicron removal, the lymph was subjected to sequential ultracentrifugation at densities 1.006, 1.063, and 1.21 g/ml (Beckman 40.3 rotor, Beckman Instruments, Inc.) for the isolation of very low density lipoproteins (VLDL), LDL, and HDL (34) . All isolated density fractions were dialyzed against NaCl-EDTA buffer before immunochemical quantitation. Heparin-Mn2+ precipitation of whole lymph was performed according to the method outlined by the Lipid Research Clinics (35) .
RESULTS
Electron microscopy. The morphology of lipoproteins from whole thoracic duct lymph collected in the presence or absence ofDTNB appears similar. Particles in the size ranges ofchylomicrons, VLDL, and LDL are easily identified in negatively stained preparations of whole lymph with DTNB (Fig. la) microns were detected in the subjects' fasting plasmas. Similarly, lymph VLDL concentrations were 320 -600% higher than plasma VLDL concentrations. Lymph VLDL also displayed a greater proportion of faster floating particles (SO 100o400)2 than plasma VLDL, which were chiefly slower floating particles (So 20-100). In contrast, lymph LDL concentrations were only 0.4-9. 1% ofplasma LDL concentrations. Except for subject C, from whom essentially no schlieren pattern was obtained, the peak flotation rates of lymph 2S? is the low density lipoprotein flotation rate, expressed in sverdbergs (10-13 centimeters per second per dyne per gram), fully corrected for concentration dependence in a NaCl medium of density 1.063 g/ml at 26°C (1.748 M NaCl).
LDL were very similar to those ofplasma LDL. Lymph HDL concentrations, as with lymph LDL, were only a fraction of plasma HDL concentrations (8-20%). In Fig. 3 the proportion of lymph HDL that exhibits the faster flotation rates of HDL2b and HDL2a (79-100%) is greater than that of plasma HDL (48-67%).
HDL composition. The weight percent composition of lymph and plasma HDL for subjects B, C, D, and E is given in Table III Apolipoprotein quantitation. The plasma and lymph concentrations of apoA-I and apoA-II are presented in Table IV for the five subjects studied. The lymph apolipoprotein concentrations represent mean concentrations for the 24-h period. The plasma apolipoprotein concentrations given for subjects C, D, and E are the means of concentrations before and after the 24-h collecting period. Both apoA-I and apoA-II concentrations in the lymph varied between 10-32% of their respective plasma values. Predicted synthesis rates and lymph apoA-I and apoA-II transport are calculated in Table IV . Although apolipoprotein transport rates vary considerably among individual subjects, lymph apolipoprotein transport was equal to and occasionally significantly (P < 0.05) greater than the predicted apolipoprotein synthesis rate. This finding is noteworthy in view ofthe large variation in the volumes of lymph flow shown in Table IV ( Apolipoprotein distribution among lipoprotein classes. ApoA-I and apoA-II concentrations determined for each lipoprotein density class present in thoracic duct lymph are shown in Table V. The major quantity of both lymph apoA-I (73-95%) and apoA-II (73-100%) was found within HDL, with almost all the remainder found in chylomicrons and VLDL. The distribution of apoA-I and apoA-II was also determined after heparin-Mn21 precipitation for subjects A and B. Lymph apoA-I and apoA-II concentrations in the heparin-Mn2+ supernate were 32+3 and 13+2 mg/dl (A) and 27±3 and 8±2 mg/dl (B). Therefore, after precipitation, 71-73% of apoA-I and 73-81% of apoA-II remained in the non-apoB-containing supernate. Whole thoracic duct lymph from subject B was also fractionated by gel permeation chromatography on Sepharose 6B-Cl (Fig.  4) . ApoA-I could be detected in the void volume frac- tions (elution position of VLDL and chylomicrons). However, the major portion (87%) eluted at the position of plasma LDL and HDL fractions. Thus, a similar distribution of apoA-I among lymph lipoproteins was obtained with each of the three fractionation techniques employed.
DISCUSSION
Fat transport and the return of filtered plasma constituents to the blood circulation are functions of human thoracic duct lymph most evident in this study. We found the daily transport of triglycerides by thoracic duct lymph chylomicrons and VLDL to represent -83% of total ingested fat in each of the five subjects. Although the exact exogenous triglyceride ingestion was not determined, an examination of the subjects' diets revealed that -95% of the ingested fat was triglyceride or fatty acid. Absorption coefficients determined for dietary fat in human subjects vary between 90 and 95% (42, 43) . The data presented here are thus consistent with the established view of exogenous fat absorption and transport; namely, transport via thoracic duct lymph into the venous circulation is the metabolic fate of virtually all absorbed exogenous fat. There remains the possibility that a small amount of absorbed fat enters the splanchnic circulation through fenestrations in the walls of its capillary endothelium.
Cholesterol transport in the five subjects was generally greater than the 0.25-0.75 g/d dietary intake. Recently, Quintao et al. (43) presented evidence that 64-100% of human mesenteric lymph cholesterol originates from plasma. The thoracic duct lymph is only partially comprised of mesenteric lymph and thus contains a potentially much larger plasma filtration component. However, -70% of the total lymph cholesterol is transported by chylomicrons and VLDL in the five subjects of this study. Therefore, the 30% of lymph cholesterol in association with HDL and LDL from these subjects may underestimate the plasma filtration component. It seems to us more likely that some of the filtered cholesterol is transferred from HDL and LDL to enrich lymph chylomicrons (43) .
In accordance with their function in fat transport, chylomicrons are the predominant lymph lipoproteins, both in mass and number. Schlieren pattern analysis indicated the presence of a considerable amount of VLDL-like particles. A distinction between large and small chylomicrons involves an operational partitioning of what appears on the schlieren pattern to be a continuum ofparticle sizes and molecular weights. A process by which cholesteryl esters and unesterified cholesterol were transferred to chylomicrons and VLDL in exchange for triglyceride would provide for the enrichment of the chylomicrons with cholesterol filtered from plasma. Accordingly, the relative cholesteryl ester content of lymph HDL is less than in plasma HDL of the five subjects presented here. Differential exchange with chylomicron triglyceride might account for the higher ratio of cholesteryl esters to unesterified cholesterol in lymph HDL as compared with plasma HDL. This discrepancy may also have to do with the origin of lymph HDL themselves. Green et al. (36) reported the isolation of disc-shaped HDL particles in rat mesenteric lymph. Although we failed to demonstrate any disclike structures in thoracic duct lymph, it is possible that an intestinal HDL particle is synthesized directly.
When compared with the predicted daily synthesis, lymph transport ofapoA-I and apoA-II was significantly greater in all five subjects. Green et al. (47) , in a study of chyluric subjects, found apoA-I and apoA-II urinary secretion rates to be 104-148% (apoA-I) and 29-66% (apoA-II) of their predicted daily synthesis. Although our results are not directly comparable to those of Green et al., both indicate a major role for lymph in the transport of apoA-I and apoA-II synthesized in the intestine. The results presented in Table IV predict that lymph apoA-I and apoA-II transport could significantly exceed their required synthesis, even if they were only synthesized in the intestine and only entered the plasma via the thoracic duct lymph.
It would therefore appear that as a lower bound, 82±70%o (SD) of lymph apoA-I and 69+10%0o of lymph apoA-II has been derived from plasma and recirculates back into the plasma each day. Assuming that only apoA-I and apoA-II in association with lymph chylomicrons represent the contribution of intestinal synthesis, a lower bound for intestinal contribution can be estimated as 26±10% of total body synthesis for apoA-I and 28±20% for apoA-II. Under this assumption, an upper bound on lymph apolipoprotein recirculation can be estimated as 156±70% for apoA-I and 126±27%
for apoA-II. Although not statistically significant, there is a tendency for lymph apoA-I transport to exceed its predicted synthesis by a relatively greater amount than for apoA-II (Table IV) . Further assumptions must be made about the lipoprotein classes that contain apolipoprotein synthesized in the intestine in order to estimate an upper bound for both intestinal apolipoprotein synthesis and extent of recirculation. Such assumptions are complicated by the possibility that the size distribution oflipoprotein particles synthesized in the intestine may be shifted towards chylomicrons or HDL depending upon high or low fat dietary intake and time of day. Indeed, Imaizumi et al. (5) , in studies of rat mesenteric lymph, reported the distribution of apoA-I between chylomicrons and HDL to be variable according to the extent of fat and cholesterol feeding. Wu and Windmueller (6) found that -34% of radioactive amino acids incorporated into apoA-I in perfused preparations of rat intestine could be isolated in chylomicrons and VLDL. The remainder was found to be associated with rat HDL. If these results can be applied to human intestinal synthesis of apoA-I and apoA-II, its upper bound can be estimated as 77±29% of total body synthesis for apoA-I and 82±59% for apoA-II. In another study, Wu and Windmueller estimated that 56% oftotal rat apoA-I synthesis takes place in the intestine (48) .
The combined results presented in this work are consistent with a major contribution ofthe intestine to total body synthesis of apoA-I and apoA-II. Hence, plasma HDL levels may be affected by factors that relate to mesenteric lymph production and ingested fat load (7) . The amount of lymph apoA-I and apoA-II that enters the plasma in association with chylomicrons represents -27% of predicted daily synthesis. The transfer of chylomicron apolipoprotein to HDL in the plasma (13, 14) thereby constitutes a quantitatively important source of HDL apolipoprotein. In patients with impaired chylomicron catabolism, significantly reduced HDL cholesterol (49) and plasma apoA-I and apoA-II concentrations (50) have been observed.
The results also suggest a vital role for the thoracic duct lymph in returning filtered apolipoprotein to plasma in association with HDL particles. The data in Tables IV and V can be used to calculate that the daily lymph contribution to plasma of apoA-I and apoA-II in association with HDL particles represents 32±14% (SD) (apoA-I) and 32+7% (apoA-II) of the total plasma apolipoprotein pool size. The lymph HDL particles returning to the plasma are primarily HDL2b and HDL2a with altered lipid and protein composition. This fact suggests that upon lymph-plasma mixing, a putative transformation of at least some of the lymph HDL2b and HDL2a particles into HDL3 particles takes place and is attended by loss of triglyceride and gain of cholesteryl ester. Finally, lymph flow, lymph composition, and capillary permeability are implicated as important physiological factors in the metabolism of human plasma HDL.
